Allogeneic stem cell transplantation

K. Sawafuji, S. Okamoto

研究成果: Review article査読

抄録

Over the last two decades, four major therapeutic approaches have dramatically changed the prognosis in chronic myelogenous leukemia(CML). Those include allogeneic stem cell transplantation, interferon-alpha based regimen, donor-leukocyte infusions, and the revolutionary BCR/ABL tyrosine kinase inhibitor such as STI571. Each modality has exploited and targeted different aspects of CML biology, and is associated with different risk-benefit ratios. In this section, we update the results of both related and unrelated donor transplantation, donor lymphocyte infusions, and non-myeloablative stem cell transplantation in CML in comparison with the other treatment modalities.

本文言語English
ページ(範囲)2375-2382
ページ数8
ジャーナルNippon rinsho. Japanese journal of clinical medicine
59
12
出版ステータスPublished - 2001 12

ASJC Scopus subject areas

  • 医学(全般)

フィンガープリント

「Allogeneic stem cell transplantation」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル